Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS)
CNY 9.37
(-0.85%)
CNY 9.37
(-0.85%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.17 Billion | 2.13 Billion | 1.99 Billion | 1.36 Billion | 1.3 Billion | 890.47 Million |
| Cost of Revenue | 1.71 Billion | 1.61 Billion | 1.25 Billion | 765.72 Million | 749.66 Million | 530.06 Million |
| Gross Profit | 464.77 Million | 512.45 Million | 747.97 Million | 601.35 Million | 559.18 Million | 360.4 Million |
| Operating Expenses | 484.13 Million | 340.55 Million | 267.84 Million | 236.06 Million | 213.03 Million | 175.26 Million |
| Selling, General and Administrative Expenses | 142.52 Million | 139.61 Million | 75.41 Million | 81.89 Million | 62.84 Million | 56.08 Million |
| Research and Development Expenses | 134.56 Million | 132.6 Million | 124.58 Million | 87.84 Million | 77.77 Million | 66.13 Million |
| Other Expenses | 207.05 Million | 68.33 Million | 67.84 Million | 66.33 Million | 72.41 Million | -8.11 Million |
| Cost and Expenses | 2.03 Billion | 1.95 Billion | 1.51 Billion | 1 Billion | 962.69 Million | 705.33 Million |
| Operating Income | 138.93 Million | 152.42 Million | 399.76 Million | 401.06 Million | 330.97 Million | 126.82 Million |
| Interest Expense | 108.65 Million | 92.6 Million | 73.82 Million | 92.04 Million | 82.61 Million | 64.99 Million |
| Income Tax Expense | 798.82 Thousand | 6.52 Million | 65.62 Million | 50.1 Million | 38.97 Million | 23.17 Million |
| Earnings before Tax | 55.33 Million | -65.4 Million | 395.39 Million | 303.69 Million | 221.89 Million | 118.71 Million |
| Net Income | 44.23 Million | -71.92 Million | 323.75 Million | 238.72 Million | 170.33 Million | 93.67 Million |
| Earnings Per Share Basic | 0.13 | -0.21 | 0.95 | 0.71 | 0.52 | 0.29 |
| Earnings Per Share Diluted | 0.13 | -0.21 | 0.95 | 0.71 | 0.52 | 0.29 |
| Weighted Average Shares Outstanding | 340.24 Million | 342.25 Million | 341.94 Million | 334.22 Million | 328.58 Million | 327.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 340.24 Million | 342.25 Million | 341.94 Million | 334.22 Million | 328.58 Million | 327.86 Million |
| Gross Margin | 0.21 | 0.24 | 0.37 | 0.44 | 0.43 | 0.40 |
| EBIT Margin | 0.15 | 0.15 | 0.32 | 0.39 | 0.34 | 0.31 |
| Profit Margin | 0.02 | -0.03 | 0.16 | 0.17 | 0.13 | 0.11 |
| EBITDA | 327.5 Million | 312.87 Million | 628.7 Million | 524.48 Million | 417 Million | 270.66 Million |
| Earnings Before Tax Margin | 0.06 | 0.07 | 0.20 | 0.29 | 0.25 | 0.14 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 469.65 Million | 683.4 Million | 637.57 Million | 561.23 Million | 2.17 Billion | 547.02 Million |
| Cost of Revenue | 373.14 Million | 558.47 Million | 499.54 Million | 440.74 Million | 1.71 Billion | 405.83 Million |
| Gross Profit | 96.51 Million | 124.93 Million | 138.03 Million | 120.49 Million | 464.77 Million | 141.19 Million |
| Operating Expenses | 96.11 Million | 96.54 Million | 95.14 Million | 104.46 Million | 325.84 Million | 91.09 Million |
| Selling, General and Administrative Expenses | 52.25 Million | 68.28 Million | 61.16 Million | 60.46 Million | - | 87.11 Million |
| Research and Development Expenses | 34.68 Million | 24.29 Million | 32.12 Million | 24.8 Million | - | 38.37 Million |
| Other Expenses | -9.17 Million | -3.96 Million | -1.85 Million | -19.19 Million | -23.27 Million | -474.09 Thousand |
| Cost and Expenses | 469.26 Million | 655.01 Million | 594.69 Million | 545.21 Million | 2.03 Billion | 496.92 Million |
| Operating Income | 397.07 Thousand | 28.39 Million | 42.88 Million | 16.02 Million | 138.93 Million | 8.52 Million |
| Interest Expense | 20 Million | 22.15 Million | 26.91 Million | 23.3 Million | 102.6 Million | 29.22 Million |
| Income Tax Expense | 1.07 Million | -1.51 Million | 5.99 Million | -1.02 Million | 798.82 Thousand | 3.82 Million |
| Earnings before Tax | -11.05 Million | 10.85 Million | 19.75 Million | 9.21 Million | 55.33 Million | 8.04 Million |
| Net Income | -13.92 Million | 10.61 Million | 12.28 Million | 4.91 Million | 44.23 Million | 4.04 Million |
| Earnings Per Share Basic | -0.03 | 0.02 | 0.04 | 0.01 | - | 0.01 |
| Earnings Per Share Diluted | -0.03 | 0.02 | 0.04 | 0.01 | - | 0.01 |
| Weighted Average Shares Outstanding | 438.4 Million | 438.4 Million | 342.51 Million | 342.51 Million | 342.15 Million | 342.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 438.4 Million | 438.4 Million | 342.51 Million | 342.51 Million | 342.15 Million | 342.51 Million |
| Gross Margin | 0.21 | 0.18 | 0.22 | 0.21 | 0.21 | 0.26 |
| EBIT Margin | 0.02 | 0.12 | 0.08 | 0.12 | - | 0.07 |
| Profit Margin | -0.03 | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 |
| EBITDA | 8.95 Million | 84.66 Million | 52.28 Million | 64.63 Million | - | 39.95 Million |
| Earnings Before Tax Margin | 0.00 | 0.04 | 0.07 | 0.03 | 0.06 | 0.02 |
UNIOFFICE
PSTO
AXREF
INTEGHIT
605577
006060